Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Stocks | 99.420 | 99.420 | 0.000 |
Preferred | 0.270 | 0.270 | 0.000 |
Other | 0.740 | 0.740 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 14.275 | 14.324 |
Price to Book | 2.302 | 1.993 |
Price to Sales | 1.713 | 1.343 |
Price to Cash Flow | 10.799 | 8.831 |
Dividend Yield | 3.292 | 3.275 |
5 Years Earnings Growth | 8.957 | 9.609 |
Name | Net % | Category Average |
---|---|---|
Financial Services | 16.930 | 17.229 |
Industrials | 16.860 | 15.916 |
Healthcare | 16.430 | 15.011 |
Consumer Cyclical | 10.720 | 10.359 |
Consumer Defensive | 10.610 | 11.523 |
Technology | 8.600 | 9.504 |
Basic Materials | 6.190 | 6.955 |
Energy | 6.050 | 5.262 |
Communication Services | 3.520 | 4.949 |
Utilities | 3.270 | 4.487 |
Real Estate | 0.790 | 1.810 |
Number of long holdings: 204
Number of short holdings: 2
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novo Nordisk B | DK0062498333 | 4.05 | 991.0 | +1.15% | |
ASML Holding | NL0010273215 | 3.74 | 953.00 | -1.40% | |
Nestle | CH0038863350 | 2.65 | 95.28 | +0.19% | |
Louis Vuitton | FR0000121014 | 2.47 | 711.40 | -2.75% | |
Shell | GB00BP6MXD84 | 2.08 | 32.25 | -0.46% | |
Novartis | CH0012005267 | 2.04 | 95.01 | +0.80% | |
AstraZeneca | GB0009895292 | 1.95 | 12,510.0 | +0.95% | |
SAP | DE0007164600 | 1.89 | 174.780 | -1.80% | |
TotalEnergies SE | FR0000120271 | 1.76 | 61.42 | -1.43% | |
Roche Holding Participation | CH0012032048 | 1.51 | 247.60 | +0.73% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
LU0058496679 | 1.65B | 13.22 | 10.74 | 11.36 | ||
LU0553726919 | 406.61M | 5.73 | -15.82 | 0.79 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review